Salvage radiation is curative in roughly half of all cases. There are many factors that contribute to an unfavorable prognosis, including waiting too long, high PSA and rapid PSA doubling time, adverse post-surgery pathology (stage, Gleason score, positive margins), and high Decipher or CAPRA-S scores. But, … READ MORE …
Filed under: Living with Prostate Cancer, Risk, Treatment | Tagged: adjuvant, outcome, PORTOS, post-surgical, progression, radiation, risk, salvage | 3 Comments »
Patrick Walsh and Nathan Laurentschuk have just published an opinion piece in European Urology taking issue with the 2013 AUA/ASTRO recommendation that adjuvant radiation is indicated for men with a pathological finding of extraprostatic extension (EPE, stage pT3a) after surgery, regardless of the surgical margin status. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, extension, extraprostatic, post-surgical, radiation, salvage, therapy | 3 Comments »
Several studies have tried to address the issue of whether adjuvant radiation actually increases prostate cancer survival in the long term compared to waiting. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, early, post-surgical, radiation, salvage | 4 Comments »
Salvage or adjuvant external beam radiation therapy for prostate cancer is usually a protracted affair, more so since we learned that a total dose of about 64 Gy to 70 Gy was needed to be effective in the salvage setting. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, hypofractionation, post-surgical, radiation, salvage, standard, stereotactic, therapy | 6 Comments »
There is increasing concurrence that the addition of GEMCaP biomarker data may be able to improve the prognostic accuracy of the Kattan post-treatment nomogram. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: biomarker, GEMCaP, Kattan, nomogram, post-surgical, prognosis | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 